Gartner Research

Life Sciences Outlook 2007: New Market Pressures Shift Priorities

Published: 21 December 2006

ID: G00183249

Analyst(s): Hussain Mooraj

Summary

Life sciences companies have enjoyed decades of strong growth because of a range of effective new treatments for a variety of diseases. However, the potential for growth and profitability is now uncertain as the industry faces an unprecedented number of challenges and uncertainties. These hurdles include pricing pressures, the cost of new products, a heightened regulatory environment, and continual business integration as a result of a spate of mergers and acquisitions.

©2019 Gartner, Inc. and/or its affiliates. All rights reserved. Gartner is a registered trademark of Gartner, Inc. and its affiliates. This publication may not be reproduced or distributed in any form without Gartner’s prior written permission. It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact. While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such. Your access and use of this publication are governed by Gartner’s Usage Policy. Gartner prides itself on its reputation for independence and objectivity. Its research is produced independently by its research organization without input or influence from any third party. For further information, see Guiding Principles on Independence and Objectivity.

Already have a Gartner Account?

Become a client